Antybiotykooporność Campylobacter - aspekty epidemiologiczne i zagrożenie zdrowia publicznego

• Autorzy: Wieczorek K. , Kania I. , Osek J.

Warianty tytułu

EN

Antimicrobial resistance of Campylobacter - epidemiological aspects and public health threat

• Języki publikacji: PL

Abstrakty

EN

Campylobacters are the most common bacterial cause of food-borne gastrointestinal infections in humans in developed countries. Macrolides and fluoroquinolones (FQ) are regarded as drugs of choice for the treatment of campylobacteriosis. Moreover, fluoroquinolones such as ciprofloxacin have been used for the first-line treatment of bacterial gastroenteritis in the absence of confirmed microbiological diagnosis. The fluoroquinolone resistance is mainly caused by a single step point mutation in the gyrase gyrA gene. The major mechanism conferring the resistance to macrolides consists of an alternation of the target site in domain V of the 23S ribosomal RNA gene. During 2004-2008 European Union Member States provided much information to EFSA on the occurrence of antimicrobial resistance in Campylobacter isolated from animals and food. Different resistance levels to antimicrobials was found among the isolates tested. For some antimicrobials, large differences in the occurrence of resistance were observed between the Member States. Some of them reported a high percentage of Campylobacter isolates recovered from poultry, pigs and cattle, as well as from meat resistant to fluoroquinolones. This suggests that due to the use of antimicrobial agents, particularly FQ, in food-producing animals, Campylobacter spp. developed resistance. Resistant strains could be transferred from animals to man by the food chain and constitute a hazard for public health; not all data, however, support this view. Some authors suggest that although some antibiotics are used in both animals and humans, most of the resistance problems in humans have arisen from human medicine. At any rate, a rational and prudent use of antibiotics in both areas is strongly recommended.

Słowa kluczowe

PL

czlowiek; zwierzeta; zagrozenia zdrowia; bakterie; Campylobacter; opornosc na antybiotyki; opornosc nabyta; opornosc krzyzowa; aspekty epidemiologiczne; zdrowie publiczne

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 04
• Opis fizyczny: s.233-239,tab.,bibliogr.

Twórcy

autor

Wieczorek K.

• Zakład Higieny Żywności Pochodzenia Zwierzęcego Państwowego Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego, Al.Partyzantów 57, 24-100 Puławy

autor

Kania I.

autor

Osek J.

Bibliografia

• 1.Bednarski M., Wieliczko A.: Antimicrobial resistance of thermophilic Campylobacter spp. isolated from cattle in Poland. Pol. J. Vet. Sci. 2010, 13, 189-191.
• 2.Cagliero C., Mouline C., Cloeckaert A., Payot S.: Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 2006, 50, 3893-3896.
• 3.Caldwell D. B., Wang Y., Lin J.: Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 2008, 52, 3947-3954.
• 4.CDC 2009. National Antimicrobial Resistance Monitoring System (NARMS): Enteric Bacteria. Human Isolates Final Report. US Department of Health and Human Services.
• 5.Chopra I., Roberts M.: Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 2001, 65, 232-260.
• 6.Dasti J. I., Gross U., Pohl S., Lugert R., Weig M., Schmidt-Ott R.: Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J. Med. Microbiol. 2007, 56, 833-837.
• 7.Engberg J., Aarestrup F. M., Taylor D. E., Gerner-Smidt P., Nachamkin I.: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 2001, 7, 24-34.
• 8.European Food Safety Authority (EFSA): The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2004-2007. EFSA Journal 2010.
• 9.European Food Safety Authority (EFSA): The Community Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from animals and food in the European Union in 2008. EFSA Journal 2010.
• 10.Fairchild A. S., Smith J. L., Idris U., Lu J., Sanchez S., Purvis L. B., Hofacre C., Lee M. D.: Effects of orally administered tetracycline on the intestinal community structure of chickens and on tet determinant carriage by commensal bacteria and Campylobacter jejuni. Appl. Environ. Microbiol. 2005, 71, 5865-5872.
• 11.Ge B., McDermott P. F., White D. G., Meng J.: Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 2005, 49, 3347-3354.
• 12.Gibreel A., Kos V. N., Keelan M., Trieber C. A., Levesque S., Michaud S., Taylor D. E.: Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 2005, 49, 2753-2759.
• 13.Gibreel A., Taylor D. E.: Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 2006, 58, 243-255.
• 14.Gibreel A., Wetsch N. M., Taylor D. E.: Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 2007, 51, 3212-3216.
• 15.Guo B., Lin J., Reynolds D. L., Zhang Q.: Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different Campylobacter species. Foodborne Pathog Dis. 2010, 7, 77-83.
• 16.Hees B. C. Van, Veldman-Ariesen M. J., de Jongh B. M., Tersmette M., van Pelt W.: Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands: an overview of 2000-2004. Clin. Microbiol. Infect. 2007, 13, 305-310.
• 17.Krutkiewicz A., Sałamaszyńska-Guz A., Rzewuska M., Klimuszko D., Binek M.: Resistance to antimicrobial agents of Campylobacter spp. strains isolated from animals in Poland. Pol. J. Vet. Sci. 2009, 12, 465-472.
• 18.Lin J., Michel L. O., Zhang Q.: CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 2002, 46, 2124-2131.
• 19.Lin J., Yan M., Sahin O., Pereira S., Chang Y. J., Zhang Q.: Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob. Agents Chemother. 2007, 51 1678-1686.
• 20.Luangtongkum T., Jeon B., Han J., Plummer P., Logue C. M., Zhang Q.: Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 2009, 4, 189-200.
• 21.Mamelli L., Prouzet-Mauléon V., Pagès J. M., Mégraud F., Bolla J. M.: Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J. Antimicrob. Chemother. 2005, 56, 491-497.
• 22.Payot S., Bolla J. M., Corcoran D., Fanning S., Mégraud F., Zhang Q.: Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect. 2006, 8, 1967-1971.
• 23.Phillips I., Casewell M., Cox T., De Groot B., Friis C., Jones R., Nightingale C., Preston R., Waddell J.: Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob. Chemother. 2004, 53, 28-52.
• 24.Pumbwe L., Piddock L. J.: Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 2002, 206, 185-189.
• 25.Rozynek E., Dzierzanowska-Fangrat K., Korsak D., Konieczny P., Wardak S., Szych J., Jarosz M., Dzierzanowska D.: Comparison of antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from humans and chicken carcasses in Poland. J. Food Prot. 2008, 71, 602-607.
• 26.Rozynek E., Dzierzanowska-Fangrat K., Szczepańska B., Wardak S., Szych J., Konieczny P., Albrecht P., Dzierzanowska D.: Trends in antimicrobial susceptibility of Campylobacter isolates in Poland (2000-2007). Pol. J. Microbiol. 2009, 58, 111-115.
• 27.Skjøt-Rasmussen L., Ethelberg S., Emborg H. D., Agersø Y., Larsen L. S., Nordentoft S., Olsen S. S., Ejlertsen T., Holt H., Nielsen E. M., Hammerum A. M.: Trends in occurrence of antimicrobial resistance in Campylobacter jejuni isolates from broiler chickens, broiler chicken meat, and human domestically acquired cases and travel associated cases in Denmark. Int. J. Food Microbiol. 2009, 31, 277-279.
• 28.Truszczyński M., Pejsak Z.: Wpływ stosowania u zwierząt antybiotyków na lekooporność bakterii chorobotwórczych dla człowieka. Medycyna Wet. 2006, 62, 1339-1343.
• 29.Wieczorek K.: Antimicrobial resistance and virulence markers of Campylobacter jejuni and Campylobacter coli isolated from retail poultry meat in Poland. Bull. Vet. Inst. Pulawy 2010, 54, 563-569.
• 30.Wieczorek K., Wasyl D., Hoszowski A., Osek J.: Wystêpowanie Campylobacter spp. w stadach brojlerów oraz Campylobacter spp. i Salmonella spp. w tuszach brojlerów w Polsce. Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy, Puławy 2009, 1-51.
• 31.Yan M., Sahin O., Lin J., Zhang Q.: Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure. J. Antimicrob. Chemother. 2006, 58, 1154-1159.
• 32.Zhao S., Young S. R., Tong E., Abbott J. W., Womack N., Friedman S. L., McDermott P. F.: Antimicrobial Resistance of Campylobacter Isolates from Retail Meat in the United States between 2002 and 2007. Appl. Environ. Microbiol. 2010, 76, 7949-7956.